Hu‐Lin Jiang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Electrospun Nanofibers in Biomedical Applications
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
Papers in
-
- Advanced Drug Delivery Systems 16
- Biomaterials 33
- Nanoparticle-Based Drug Delivery 23
- Co-authors
- Lei XingChong‐Su ChoMyung‐Haing ChoPeng‐Fei CuiYou-Kyoung KimTian‐Jiao ZhouYun‐Jaie ChoiRohidas Arote
- Journals
- Journal of Controlled Release (21 papers)Biomaterials (18 papers)International Journal of Pharmaceutics (14 papers)Chinese Chemical Letters (7 papers)Journal of Nanoscience and Nanotechnology (7 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Hu‐Lin Jiang
184 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Biomaterials 1.8k
- Pharmaceutical Science 474
- Biomedical Engineering 2.2k
- Molecular Medicine 221
- Molecular Biology 3.0k
Countries citing papers authored by Hu‐Lin Jiang
This map shows the geographic impact of Hu‐Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu‐Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu‐Lin Jiang more than expected).
Fields of papers citing papers by Hu‐Lin Jiang
This network shows the impact of papers produced by Hu‐Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu‐Lin Jiang. The network helps show where Hu‐Lin Jiang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hu‐Lin Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2024 | 27 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 13 | |
| 10 | 2024 | 12 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 19 | |
| 13 | 2023 | 25 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 50 | |
| 16 | 2020 | 9 | |
| 17 | 2017 | 83 | |
| 18 | 2017 | 50 | |
| 19 | 2016 | 5 | |
| 20 | Gene Expression and Pulmonary Toxicity of Chitosan-graft- Polyethylenimine as Aerosol Gene Carrier. | 2013 | 6 |
About Hu‐Lin Jiang
Hu‐Lin Jiang is a scholar working on Pharmaceutical Science, Biomaterials, Hepatology, Microbiology and Molecular Biology, having authored 195 papers that have together received 6.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (68 papers), Advanced biosensing and bioanalysis techniques (40 papers), Virus-based gene therapy research (35 papers), Nanoplatforms for cancer theranostics (25 papers), Nanoparticle-Based Drug Delivery (23 papers), Advanced Drug Delivery Systems (16 papers), Liver physiology and pathology (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). The work is most often cited by research in Biomaterials (1.8k citations), Pharmaceutical Science (474 citations), Biomedical Engineering (2.2k citations), Molecular Medicine (221 citations) and Molecular Biology (3.0k citations). Hu‐Lin Jiang has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Lei Xing, Chong‐Su Cho, Myung‐Haing Cho, Peng‐Fei Cui, You-Kyoung Kim, Tian‐Jiao Zhou, Yun‐Jaie Choi, Rohidas Arote, Yujing He and Toshihiro Akaike. Their work appears in journals such as Journal of Controlled Release, Biomaterials, International Journal of Pharmaceutics, Chinese Chemical Letters and Journal of Nanoscience and Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.